There are three main types of drug interactions: drugs with food and beverages, drugs with dietary supplements, and drugs with other drugs. In this Consumer Update video, Shiew-Mei Huang, Ph.D., Deputy Director of FDA's Office of Clinical Pharmacology, provides tips on how to avoid harmful drug interactions.
Every year thousands of children are hospitalized and some die after taking medicine not meant for them. Teens share stolen prescription drugs at "pharm parties" and toddlers are tempted by colorful pills that look like candy. In this Consumer Update video, FDA pharmacist Connie Jung explains how you can prevent harm by locking your medicine up.
Ortho-McNeil-Janssen is notifying healthcare professionals about strengthened warnings for Ultram (tramadol hydrochloride) and Ultracet (tramadol hydrochloride/acetaminophen). These drugs contain tramadol, which is a synthetic opioid analgesic used to manage chronic pain.
FDA is notifying healthcare professionals that patients with moderate to severe hepatic impairment who are beginning therapy with Velcade (bortezomib) should be started at reduced doses and closely monitored for toxicity. This recommendation does not apply to those with mild hepatic impairment. Velcade is used to treat patients with multiple myeloma and those with mantle cell lymphoma who have received at least one prior therapy.
Epinephrine inhalers that use chlorofluorocarbons (CFCs) as a propellant will no longer be sold in the U.S. after December 31, 2011. CFCs released into the environment damage the ozone layer in the atmosphere.
FDA is warning people about harmful effects in children and pets if they unintentionally come in contact with Evamist (estradiol transdermal spray), a topical hormone treatment used to relieve hot flashes in post-menopausal women. This can lead to premature puberty in girls and breast enlargement in boys. Similar effects have been observed in exposed pets.